Nordea Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71M Buy
205,273
+140,730
+218% +$5.07M 0.01% 546
2026
Q1
$2.19M Sell
64,543
-3,005
-4% -$122K ﹤0.01% 735
2025
Q4
$2.72M Sell
67,548
-9,415
-12% -$410K ﹤0.01% 712
2025
Q3
$3.55M Buy
76,963
+1,522
+2% +$78.9K ﹤0.01% 655
2025
Q2
$3.95M Buy
75,441
+520
+0.7% +$28.5K ﹤0.01% 602
2025
Q1
$4.39M Buy
74,921
+1,334
+2% +$86K ﹤0.01% 558
2024
Q4
$5.14M Buy
73,587
+17,633
+32% +$1.23M 0.01% 529
2024
Q3
$4.18M Sell
55,954
-2,513
-4% -$177K ﹤0.01% 561
2024
Q2
$4M Buy
+58,467
New +$4.26M ﹤0.01% 568

Other funds holding CNMD

Nordea Investment Management's CNMD Position: Q2 2026 in Review

Nordea Investment Management increased its CONMED (CNMD) stake by 218% in Q2 2026, buying an estimated $5.07M and bringing the position to 205,273 shares worth $6.71M. The position accounts for 0.01% of the portfolio, ranked #546.

Nordea Investment Management first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Nordea Investment Management held 205,273 shares of CONMED worth $6.71M as of Q2 2026.
  • Nordea Investment Management bought 140,730 CONMED shares in Q2 2026, an estimated $5.07M.
  • CONMED made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #546 holding.
  • Nordea Investment Management first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.